Gt Biopharma Inc (GTBP)

01:09 AM

GT Biopharma Inc Stock Analysis and ForecastDay Trading Setups & Free Lightning Fast Capital Gains - earlytimes.in

01:09 AM

Dec 05, 2025

Why GT Biopharma Inc. (OXIA) stock could rally stronglyJuly 2025 Recap & Daily Price Action Insights - Newser

Dec 05, 2025

Dec 04, 2025

GT Biopharma Inc OXIA Stock Analysis and ForecastMarket Sentiment Shifts & Affordable Portfolio Trading - earlytimes.in

Dec 04, 2025

Dec 04, 2025

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - The Malaysian Reserve

Dec 04, 2025

Dec 04, 2025

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga

Dec 04, 2025

Dec 04, 2025

GT Biopharma (GTBP) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025

Dec 04, 2025

What technical charts say about GT Biopharma Inc. stockTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser

Dec 04, 2025

Dec 04, 2025

What is the fair value estimate for GT Biopharma Inc. (OXIA) stock in 2025July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser

Dec 04, 2025

Dec 03, 2025

The growth track for GT Biopharma Inc (GTBP) has changed recently - Setenews

Dec 03, 2025

Dec 03, 2025

What Wall Street predicts for GT Biopharma Inc. stock priceTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser

Dec 03, 2025

Dec 02, 2025

Is GT Biopharma Inc. (OXIA) stock a buy on weaknessWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser

Dec 02, 2025

Dec 02, 2025

How supply chain issues affect GT Biopharma Inc. stockRate Hike & Consistent Income Trade Ideas - Newser

Dec 02, 2025

Dec 02, 2025

How reliable is GT Biopharma Inc. (OXIA) stock dividend growthWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser

Dec 02, 2025

Nov 29, 2025

What drives GT Biopharma Inc stock priceShort Interest Overview & Superior Trading Portfolio - earlytimes.in

Nov 29, 2025

Nov 26, 2025

GT Biopharma faces Nasdaq bid-price deficiency, eyes compliance options - Stock Titan

Nov 26, 2025

Nov 24, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: GT Biopharma Inc (GTBP) - Setenews

Nov 24, 2025

Nov 24, 2025

GT Biopharma shares advance as flagship GTB 3650 trial escalates to next dose level - MSN

Nov 24, 2025

Nov 21, 2025

GT Biopharma (GTBP) Price Target Decreased by 27.27% to 8.16 - MSN

Nov 21, 2025

Nov 21, 2025

How GT Biopharma Inc. (OXIA) stock responds to job market shiftsMarket Growth Report & Growth Oriented Trade Recommendations - newser.com

Nov 21, 2025

Nov 20, 2025

Is GT Biopharma Inc. (OXIA) stock a fit for income portfoliosPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Will GT Biopharma Inc. (OXIA) stock extend growth storyWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Will GT Biopharma Inc. (OXIA) stock deliver compounding returns2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Is GT Biopharma Inc. stock attractive for income investorsWatch List & Stepwise Entry and Exit Trade Signals - newser.com

Nov 20, 2025

Nov 19, 2025

Developing predictive dashboards with GT Biopharma Inc. dataChart Signals & Daily Entry Point Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is GT Biopharma Inc. trending in predictive chart models2025 Price Targets & Weekly Stock Breakout Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will GT Biopharma Inc. bounce back from current supportQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com

Nov 19, 2025

Nov 19, 2025

Is GT Biopharma Inc. (OXIA) stock positioned for secular growth2025 Big Picture & Capital Efficiency Focused Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Tools to monitor GT Biopharma Inc. recovery probabilityMarket Risk Report & Real-Time Market Trend Scan - newser.com

Nov 19, 2025

Nov 19, 2025

GT Biopharma stock rises as Phase 1 trial advances to higher dose - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

GT Biopharma stock rises as Phase 1 trial advances to higher dose By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials - ACCESS Newswire

Nov 19, 2025